LENSAR, Inc.

LNSR Medical devices

Develops laser systems for cataract surgery and astigmatism management.

Jun 2026Revenue $60.3M/yrExpenses $68.4M/yr
No trendCash runway ≈ 1.9 years from Jun 2026
Figures by year

When will LENSAR be profitable?

Its figures don’t show a steady enough trend to project a date. In the 12 months to Jun 2026, revenue was $60.3M and expenses $68.4M.

Fiscal year toRevenueExpensesOperating profit
Dec 2025$58.4M$83.0M−$24.6M
Dec 2024$53.5M$64.2M−$10.7M
Dec 2023$42.2M$54.4M−$12.2M
Dec 2022$35.4M$55.5M−$20.2M
Dec 2021$34.5M$54.1M−$19.7M
Dec 2020$26.4M$44.9M−$18.5M
Dec 2019$30.5M$43.2M−$12.7M